Health and Healthcare
1079 Articles
Merck (MRK) and Schering-Plough (SGP) make two of the most widely sold drugs in the world. One is cholesterol drug…
Texas Instruments (TXN) Bad earnings take chip company down. Falls to $23.28 from 52-week high of $38.79. AMD (AMD) Chip…
According to Reuters, Apple (AAPL) missed Wall St. expectations, sending the stock down by 10%. Reuters reports that American Express…
Merck & Co. (NYSE: MRK) posted earnings that look pretty good on the surface. The problem is that the surface…
These are not all of the upgrades or positive analyst calls seen this morning but these are some of the…
According to Reuters, Robert Steel was named the new CEO of Wachovia (WB) and the bank said it would have…
We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic…
According to Reuters, Microsoft (MSFT) is willing to start buy-out talks with Yahoo! (YHOO) if the portal company will replace…
These are ten of the analyst calls with upgrades and downgrades we are focusing on this Monday morning in pre-market…
We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and…
It used to be that DEFENSIVE STOCKS were the way to go during periods of uncertainty and during times of…
Today’s 52-week low list was full of some of the usual suspects, and you can count airlines as the top…
According to Reuters, Microsoft’s (MSFT) Steve Ballmber said his company will not bid for Yahoo! (YHOO). Reuters writes that HP’s…
Shares of Amgen Inc. (NASDAQ: AMGN) are seeing a small gain in after-hours trading. The troubled biotech giant announced that…
Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its…
Our top personal finance-related articles today. Your wallet will thank you later.